Guangji Pharmaceutical: Subsidiary Guanghua Pharmaceutical plans to increase capital and introduce investors through stock expansion.

GoldenOctober2024

2024-11-15 08:54:36

Data Jinshi, 15 November, Guangji Pharmaceutical announced in the evening that its wholly-owned subsidiary, Hubei Guanghua Pharmaceutical Co., Ltd., plans to pre-list on the Shanghai United Property Exchange, and introduce strategic investors through capital increase and share expansion. The identity of the counterparty in this transaction is not yet determined, and it cannot be determined at the moment whether it constitutes a related party transaction. The proportion of the final capital increase, the amount of the capital increase, and other details are currently not determined.

Lihat Asli

Halaman ini mungkin berisi konten pihak ketiga, yang disediakan untuk tujuan informasi saja (bukan pernyataan/jaminan) dan tidak boleh dianggap sebagai dukungan terhadap pandangannya oleh Gate, atau sebagai nasihat keuangan atau profesional. Lihat Penafian untuk detailnya.